Newsroom | 27462 results

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, der Marktführer im Bereich der KI-gestützten Krankheitserkennung und intelligenten Versorgungskoordination, gab heute eine Zusammenarbeit mit Cortechs.ai bekannt, einem weltweit führenden Anbieter von Lösungen für Neuroimaging und quantitative Analyse. Ziel ist die Integration der NeuroQuant- und NeuroQuant MS-Suite von Cortechs.ai in die Viz.ai-Plattform, um Krankenhäusern und Gesundheitssystemen in den gesamten USA den Zugang zu quantitativem Neuroimagi...

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, le leader dans les domaines de la détection des maladies et de la coordination intelligente des soins alimentées par l’IA, a annoncé aujourd’hui une collaboration avec Cortechs.ai, un acteur de premier plan dans le secteur des solutions de neuro-imagerie et d’analyse quantitative, afin d’intégrer la suite NeuroQuant et NeuroQuant MS de Cortechs.ai à la plateforme Viz.ai. Cette intégration permettra d’élargir l’accès à la neuro-imagerie quantitative pour l...

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, líder en coordinación de atención inteligente y detección de enfermedades con tecnología de IA, anunció hoy una colaboración con Cortechs.ai, líder en soluciones de neuroimágenes y análisis cuantitativo a nivel mundial, para integrar el paquete de software NeuroQuant y NeuroQuant de Cortechs.ai en la plataforma de Viz.ai con el objetivo de ampliar el acceso a neuroimágenes cuantitativas para hospitales y sistemas de salud en los Estados Unidos. Esta alian...

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, leider in detectie van ziekten aangestuurd door AI en intelligente zorgcoördinatie, kondigde vandaag een samenwerking aan met Cortechs.ai, een internationale leider in oplossingen voor neuroimaging en kwantitatieve analyse, om Cortechs.ai's NeuroQuant- en NeuroQuant MS-aanbod te integreren in het Viz.ai-platform en zo toegang tot kwantitatieve neuroimaging uit te breiden voor ziekenhuizen en gezondheidssystemen in de V.S. Dit partnerschap markeert Viz.ai'...

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, il leader nel rilevamento di malattie e nel coordinamento intelligente dell'assistenza potenziati dall'intelligenza artificiale, oggi ha annunciato una collaborazione con Cortechs.ai, un leader globale nelle soluzioni di neuroimaging e analisi quantitativa, per integrare NeuroQuant e la suite NeuroQuant MS di Cortechs.ai nella piattaforma Viz.ai, ampliando l'accesso al neuroimaging quantitativo per gli ospedali e le strutture sanitarie in tutti gli Stati...

EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its second quarter 2026 financial results after the market closes on Thursday, July 30, 2026. Management will host a conference call for the investment community the same day at 4:30 PM ET (1:30 PM PT) to discuss the results and answer que...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the second quarter 2026 after the close of market on Thursday, July 30, 2026. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day. The conference call will be webcast live from the company’s website and will b...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2026 after market close on Thursday, July 30, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of the company website at: www.guardanthealth.com. The webcast will...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported financial results for its third quarter fiscal 2026, ended May 31, 2026. Third Quarter 2026 Financial Highlights (as compared to third quarter 2025) Total revenue increased 7% to $21.9 million Software revenue was flat at $12.6 million, representing 58% o...

PARK CITY, Jūta--(BUSINESS WIRE)--„NordicTrack Ultra 1“ ir ieguvis „Red Dot“ balvu par produkta dizainu — vienu no senākajām un prestižākajām atzinībām šajā jomā. Mazāk nekā gada laikā šis skrejceļš ir izcelts jau trešo reizi: žurnāls „Esquire“ to atzina par „Gada ierīci“, žurnāls „TIME“ iekļāva to savā 2025. gada labāko izgudrojumu sarakstā, un tagad arī „Red Dot“ žūrija ir pievienojusi savu atzinību. „NordicTrack“ jau piecus gadu desmitus ražo mājas fitnesa trenažierus, un modelis „Ultra 1“ i...